Anavar 20 - Gen-Shi Laboratories

Oxandrolone holds a unique place among anabolic steroids for being introduced with direct medical purpose. It entered the market in 1962 as Anavar, formulated by G.D. Searle & Co. to provide anabolic therapy with reduced androgenic risk. It became widely accepted for helping patients recover from severe trauma, illness, or hormone deficiency. Over time, its off-label use by athletes led to controversy and removal in 1989. Reintroduced as Oxandrin in 1995 by BTG, it is now reserved for specific disorders under regulatory control as an orphan-designated therapeutic agent.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Anavar 20 by Gen-Shi Laboratories, consult with your doctor or healthcare professional.